hematologic premalignant conditions | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

17,450 results for “hematologic premalignant conditions”

Trials

View all 7775 →

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

6 participants · First posted Jan 27, 2003

Ruxolitinib for Premalignant Breast Disease

84 participants · First posted Oct 10, 2016

Nutritional and Physical Exercise Intervention in Older Patients With Malignant Hemopathies

80 participants · First posted Aug 15, 2019

Drugs

View all 196 →

extracellular vesicle therapy (orthopedic conditions)

Solid & hematologic malignancies(Notch)

Neurological conditions program(C4 therapeutics/Biogen)

Organizations

View all 70 →

Disc Medicine

United States

Legend Biotech Corporation

United States

Atara Biotherapeutics

United States

News

View all 9409 →

UNR Med Resident Research Day Highlights Hematologic Premalignancy Research and Vaccine Effectiveness Studies

Society of Hematologic Oncology Launches Second Educational Podcast, SOHO Spotlight, on Hematologic Malignancy Management

EHA 2025 Showcases Breakthrough Therapies for Hematologic Malignancies

Page 1 of 1745